{"doi":"10.1161/circoutcomes.121.008704","title":"Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage","abstract":"The coronavirus disease 2019 (COVID-19) pandemic and the policies designed to mitigate its morbidity and mortality continue to alter the societal structure within the United States in ways that compound socioeconomic vulnerabilities among Americans.This intensification of social disadvantage in 2020 compared with 2019 include a 2.9% decline in median household income with a greater decline of 5.7% among house-holds with low educated adults. 1 In addition, there was an overall 1% growth in the poverty rate resulting in an additional 3.3 million Americans in poverty and a 1.6% increase in child poverty. 1 Adults having at least one disability experienced the greatest rise in poverty of 2.5%.Furthermore, there were disproportionate economic effects of the pandemic by race/ethnicity in the United States, with Hispanic Americans experiencing the largest increase in poverty of 1.3%. 1 Income, employment, education, food security, housing quality, and an array of other social factors that describe the circumstances in which people are born, grow, live, learn, work, worship, and age are not only threads of the societal fabric frayed in the proverbial war against COVID-19 but they are also well-known social determinants of cardiovascular conditions, including hypertension. 2ult hypertension and its prevalence of 47.3% in the United States remains not only a serious public health challenge for the nation, but worldwide. 3The World Health Organization estimates that 1.4 billion adults across the globe have hypertension, with only 14% having the medical condition under control, that is, blood pressure below 130/80 mm Hg, through lifestyle modifications or the use of pharmacological agents. 4Furthermore,","journal":"Circulation Cardiovascular Quality and Outcomes","year":2022,"id":298141,"datarank":0.29188652235829704,"base_score":1.9459101490553132,"endowment":1.9459101490553132,"self_citation_contribution":0.29188652235829704,"citation_network_contribution":0.0,"self_endowment_contribution":0.29188652235829704,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9593,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":281794,"name":"Tiffany M. Powell‐Wiley","orcid":"0000-0001-9488-4131","position":1,"is_corresponding":false},{"id":986772,"name":"Debbie S. Barrington","orcid":"0000-0001-7921-2724","position":0,"is_corresponding":true}],"reference_count":6,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T00:31:31.270564Z","pmid":"35098733","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}